Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...
French ministers report Grok's sex-related content on the X platform to prosecutors French ministers have reported to prosecutors sexually explicit content generated by Elon Musk's xAI artificial ...